Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: Circ Heart Fail. 2012 Mar 1;5(2):176–182. doi: 10.1161/CIRCHEARTFAILURE.111.963793

Table 2.

Baseline characteristics at study entry for 39,815 women free of cardiovascular disease and heart failure at baseline

Characteristic Vitamin E
(n=19913)
Placebo
(n=19902)
Age, %
   45–54 y 60.3 60.3
   55–64 y 29.5 29.5
   >=65 y 10.2 10.3
Non-Hispanic White race/ethnicity, % 94.7 94.9
Hypertension, % 25.6 26.1
Hypercholesterolemia, % 29.3 29.6
Diabetes, % 2.9 2.8
Smoking, %
   Current smoking 13.0 13.3
   Past smoking 36.1 35.6
   Never smoking 51.0 51.2
Body mass index, %
   <25.0 kg/m2 50.5 50.8
   25.0–29.9 kg/m2 31.2 30.9
   >=30 kg/m2 18.3 18.3
Menopausal status and hormone therapy use, %
   Premenopausal 27.5 27.8
   Uncertain/perimenopausal 17.9 18.0
   Postmenopausal and current hormone therapy 30.1 30.0
   Postmenopausal and no hormone therapy 24.5 24.2
Physical activity (at least 1000 kcal/week in leisure-time activities) 33.7 34.2
Alcohol consumption (at least 1 drink per month), % 54.6 55.3
Multivitamin use, % 39.2 38.4
Aspirin assignment, % 50.0 50.0
Beta carotene assignment, % 50.0 50.0